Meeting
2023 ASCO Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate- and poor-risk metastatic germ cell tumours (GCTs).
Authors
Danka Zebic
NHMRC Clinical Trials Centre
Danka Zebic , Martin Stockler , Andrew Martin , Farzana Pashankar , Ben Tran , Danish Mazhar , Robert Huddart , Matthew Wheater , Euan Walpole , Elaine Dunwoodie , Darren Feldman , Alison Birtle , Amanda Stevanovic , David Wyld , Fritha Hanning , Peter Grimison
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Cancer Disparities
Clinical Trial Registration Number
NCT02582697
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr TPS431)
Abstract #
TPS431
Poster Bd #
N13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Danka Sinikovic Zebic
Poster
2018 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison
Poster
2018 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Namrata Nayar
Poster
2017 ASCO Annual Meeting
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
First Author: Peter S. Grimison